» Articles » PMID: 30538706

Glycans As Key Checkpoints of T Cell Activity and Function

Overview
Journal Front Immunol
Date 2018 Dec 13
PMID 30538706
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

The immune system is highly controlled and fine-tuned by glycosylation, through the addition of a diversity of carbohydrates structures (glycans) to virtually all immune cell receptors. Despite a relative backlog in understanding the importance of glycans in the immune system, due to its inherent complexity, remarkable findings have been highlighting the essential contributions of glycosylation in the regulation of both innate and adaptive immune responses with important implications in the pathogenesis of major diseases such as autoimmunity and cancer. Glycans are implicated in fundamental cellular and molecular processes that regulate both stimulatory and inhibitory immune pathways. Besides being actively involved in pathogen recognition through interaction with glycan-binding proteins (such as C-type lectins), glycans have been also shown to regulate key pathophysiological steps within T cell biology such as T cell development and thymocyte selection; T cell activity and signaling as well as T cell differentiation and proliferation. These effects of glycans in T cells functions highlight their importance as determinants of either self-tolerance or T cell hyper-responsiveness which ultimately might be implicated in the creation of tolerogenic pathways in cancer or loss of immunological tolerance in autoimmunity. This review discusses how specific glycans (with a focus on -linked glycans) act as regulators of T cell biology and their implications in disease.

Citing Articles

Post-translational modifications in hepatocellular carcinoma: unlocking new frontiers in immunotherapy.

Piao Y, Zhai N, Zhang X, Zhao W, Li M Front Immunol. 2025; 16:1554372.

PMID: 40040703 PMC: 11876159. DOI: 10.3389/fimmu.2025.1554372.


Temporal resolved multi-proteomic analysis enabled the systematic characterization of N-glycosylation pattern changes during Jurkat T cell activation.

Dong M, Liu X, Zhao C, Fang Z, Wang Z, Guo X Anal Bioanal Chem. 2025; .

PMID: 39998645 DOI: 10.1007/s00216-025-05805-3.


Dichotomous effects of Galectin-9 in disease modulation in murine models of inflammatory bowel disease.

Tull S, Saviano A, Fatima A, Begum J, Mansour A, Marigliano N Biomed Pharmacother. 2025; 184:117902.

PMID: 39951917 PMC: 11870847. DOI: 10.1016/j.biopha.2025.117902.


Single-Cell Multiomics Identifies Glycan Epitope LacNAc as a Potential Cell-Surface Effector Marker of Peripheral T Cells in Bladder Cancer Patients.

Wu X, Zhao Z, Yu W, Liu S, Zhou M, Jiang N ACS Chem Biol. 2024; 19(12):2535-2547.

PMID: 39582226 PMC: 11668243. DOI: 10.1021/acschembio.4c00635.


Antibody-targeted T cells and natural killer cells for cancer immunotherapy.

Sutherland A, Parlekar B, Livingstone D, Medina A, Bernhard W, Garcia T J Nanobiotechnology. 2024; 22(1):640.

PMID: 39425222 PMC: 11488284. DOI: 10.1186/s12951-024-02898-3.


References
1.
Monney L, Sabatos C, Gaglia J, Ryu A, Waldner H, Chernova T . Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002; 415(6871):536-41. DOI: 10.1038/415536a. View

2.
van Liempt E, Bank C, Mehta P, Garcia-Vallejo J, Kawar Z, Geyer R . Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett. 2006; 580(26):6123-31. DOI: 10.1016/j.febslet.2006.10.009. View

3.
Shih H, Hao B, Krangel M . Orchestrating T-cell receptor α gene assembly through changes in chromatin structure and organization. Immunol Res. 2010; 49(1-3):192-201. PMC: 3350817. DOI: 10.1007/s12026-010-8181-y. View

4.
Garcia-Vallejo J, Ilarregui J, Kalay H, Chamorro S, Koning N, Unger W . CNS myelin induces regulatory functions of DC-SIGN-expressing, antigen-presenting cells via cognate interaction with MOG. J Exp Med. 2014; 211(7):1465-83. PMC: 4076586. DOI: 10.1084/jem.20122192. View

5.
Perdicchio M, Ilarregui J, Verstege M, Cornelissen L, Schetters S, Engels S . Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells. Proc Natl Acad Sci U S A. 2016; 113(12):3329-34. PMC: 4812702. DOI: 10.1073/pnas.1507706113. View